Rewrite Identification of an allosteric site on the E3 ligase adapter cereblon as a headline for a science magazine post, using no more than 7 words
Cereblon (CRBN) is the target of thalidomide derivatives1 that achieve therapeutic efficacy against some haematologic neoplasias2,3,4 by recruiting neosubstrates for degradation5,6,7. Despite the intense investigation...














